• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Hamilton Lane Incorporated (Amendment)

    3/24/23 4:14:48 PM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email
    SC 13D/A 1 hlschedule13dmarch2023.htm SC 13D/A Document
    SCHEDULE 13D/A
    CUSIP No. 407497 106
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13D
    Under the Securities Exchange Act of 1934*
    (Amendment No. 10)
    Hamilton Lane Incorporated
    (Name of Issuer)
    Class A Common Stock, par value $0.001
    (Title of Class of Securities)
    407497 106
    (CUSIP Number)
    Lydia Gavalis
    General Counsel and Secretary
    Hamilton Lane Incorporated
    110 Washington Street, Suite 1300
    Conshohocken, PA 19428
    Telephone: (610) 934-2222
     
    with a copy to:
     
    Matthew H. Meyers
    Faegre Drinker Biddle & Reath LLP
    One Logan Square, Suite 2000
    Philadelphia, PA 19103
    Telephone: (215) 988-2700
    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    March 9, 2023
    (Date of Event Which Requires Filing of this Statement)

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: o
    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for other parties to whom copies are to be sent.
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    HLA Investments, LLC
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    Delaware
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    18,023,993
    (9)
    Sole Dispositive Power
    9,733,672
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    18,023,993
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    33.2%
     (14)
    Type of Reporting Person (See Instructions)
    OO (Limited Liability Company)

    2

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    HRHLA, LLC
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    Delaware
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    18,023,993
    (9)
    Sole Dispositive Power
    7,300,667
    (10)
    Shared Dispositive Power
    2,563,005
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    18,023,993
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    33.2%
     (14)
    Type of Reporting Person (See Instructions)
    OO (Limited Liability Company)
     

    3

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Hartley R. Rogers
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
     OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    18,023,993
    (9)
    Sole Dispositive Power
    7,311,170
    (10)
    Shared Dispositive Power
    2,563,005
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    18,023,993
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    33.2%
     (14)
    Type of Reporting Person (See Instructions)
    IN

    4

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Hamilton Lane Advisors, Inc.
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    Pennsylvania
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    2,579,104
    (9)
    Sole Dispositive Power
    2,579,104
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    2,579,104
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    6.3%
     (14)
    Type of Reporting Person (See Instructions)
    CO


    5

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Mario L. Giannini
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    3,408,829
    (9)
    Sole Dispositive Power
    3,125,197
    (10)
    Shared Dispositive Power
    283,632
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    3,408,829
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    8.1%
     (14)
    Type of Reporting Person (See Instructions)
    IN

    6

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Kyera Giannini
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    288,648
    (9)
    Sole Dispositive Power
    288,648
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    288,648
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.7%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    7

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Nicole Giannini
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
     OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    288,648
    (9)
    Sole Dispositive Power
    288,648
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    288,648
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.7%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    8

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    The 2008 Sexton Des. Trust FBO Laura Sexton
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    New York
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    366,233
    (9)
    Sole Dispositive Power
    0
    (10)
    Shared Dispositive Power
    366,233
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    366,233
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.9%
     (14)
    Type of Reporting Person (See Instructions)
    OO (Trust)


    9

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    The 2008 Sexton Des. Trust FBO Matthew Sexton
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    New York
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    366,233
    (9)
    Sole Dispositive Power
    0
    (10)
    Shared Dispositive Power
    366,233
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    366,233
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.9%
     (14)
    Type of Reporting Person (See Instructions)
    OO (Trust)


    10

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    O. Griffith Sexton
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    749,880
    (9)
    Sole Dispositive Power
    17,414
    (10)
    Shared Dispositive Power
    732,466
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    749,880
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    1.9%
     (14)
    Type of Reporting Person (See Instructions)
    OO (Trustee), IN



    11

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Oakville Number 2 Trust
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    Guernsey
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    535,022
    (9)
    Sole Dispositive Power
    0
    (10)
    Shared Dispositive Power
    535,022
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    535,022
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    1.4%
     (14)
    Type of Reporting Person (See Instructions)
    OO (Trust)


    12

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Rysaffe Trust Company (C.I.) Limited
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    Guernsey
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    535,022
    (9)
    Sole Dispositive Power
    0
    (10)
    Shared Dispositive Power
    535,022
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    535,022
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    1.4%
     (14)
    Type of Reporting Person (See Instructions)
    OO (Trustee)



    13

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Edward B. Whittemore
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    130,000
    (9)
    Sole Dispositive Power
    0
    (10)
    Shared Dispositive Power
    130,000
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    130,000
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.3%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    14

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Laurence F. Whittemore
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    156,880
    (9)
    Sole Dispositive Power
    0
    (10)
    Shared Dispositive Power
    156,880
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    156,880
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.4%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    15

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Michael Schmertzler
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    725,005
    (9)
    Sole Dispositive Power
    0
    (10)
    Shared Dispositive Power
    725,005
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    725,005
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    1.8%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    16

    SCHEDULE 13D/A
    CUSIP No. 407497 106
    (1)
    Name of Reporting Person
    Erik R. Hirsch
    (2)Check the Appropriate Box if a Member of a Group
     (a)x
     (b)¨
    (3)SEC Use Only
    (4)
    Source of Funds
    OO
    (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
    (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    1,192,552
    (9)
    Sole Dispositive Power
    1,192,552
    (10)
    Shared Dispositive Power
    0
    (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    1,192,552
    (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
    (13)
    Percent of Class Represented by Amount in Row (11)
    3.0%
    (14)
    Type of Reporting Person (See Instructions)
    IN

    17

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Juan Delgado-Moreira
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    Spain
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    1,280,902
    (9)
    Sole Dispositive Power
    1,280,902
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    1,280,902
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    3.3%
     (14)
    Type of Reporting Person (See Instructions)
    IN



    18

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Paul Yett
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    231,129
    (9)
    Sole Dispositive Power
    231,129
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    231,129
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.6%
     (14)
    Type of Reporting Person (See Instructions)
    IN

    19

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Kevin J. Lucey
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    216,426
    (9)
    Sole Dispositive Power
    216,426
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    216,426
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.6%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    20

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Tara Devlin
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    221,850
    (9)
    Sole Dispositive Power
    221,850
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    221,850
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.6%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    21

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Stephen R. Brennan
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    230,184
    (9)
    Sole Dispositive Power
    230,184
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    230,184
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.6%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    22

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Andrea Anigati
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    449,930
    (9)
    Sole Dispositive Power
    449,930
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    449,930
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    1.2%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    23

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Michael Kelly
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    100,000
    (9)
    Sole Dispositive Power
    100,000
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    100,000
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.3%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    24

    SCHEDULE 13D/A
    CUSIP No. 407497 106
    (1)
    Name of Reporting Person
    Thomas Kerr
    (2)Check the Appropriate Box if a Member of a Group
     (a)x
     (b)
    ¨
    (3)SEC Use Only
    (4)
    Source of Funds
    OO
    (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
    (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    196,138
    (9)
    Sole Dispositive Power
    196,138
    (10)
    Shared Dispositive Power
    0
    (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    196,138
    (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
    (13)
    Percent of Class Represented by Amount in Row (11)
    0.5%
    (14)
    Type of Reporting Person (See Instructions)
    IN

    25

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    David Helgerson
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)
    ¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    199,477
    (9)
    Sole Dispositive Power
    199,477
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    199,477
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.5%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    26

    SCHEDULE 13D/A
    CUSIP No. 407497 106
     (1)
    Name of Reporting Person
    Michael Donohue
     (2)Check the Appropriate Box if a Member of a Group
      (a)x
      (b)¨
     (3)SEC Use Only
     (4)
    Source of Funds
    OO
     (5)
    Check box if Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e) ¨
     (6)
    Citizenship or Place of Organization
    U.S.A.
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (7)
    Sole Voting Power
    0
    (8)
    Shared Voting Power
    62,094
    (9)
    Sole Dispositive Power
    62,094
    (10)
    Shared Dispositive Power
    0
     (11)
    Aggregate Amount Beneficially Owned by Each Reporting Person
    62,094
     (12)
    Check box if the Aggregate Amount in Row (11) Excludes Certain Shares ¨
     (13)
    Percent of Class Represented by Amount in Row (11)
    0.2%
     (14)
    Type of Reporting Person (See Instructions)
    IN


    27

    SCHEDULE 13D/A
    CUSIP No. 407497 106
    Item 1. Security and Issuer
     
        This Amendment No. 10 to Schedule 13D (this “Amendment No. 10”) is being filed with respect to the Class A Common Stock, $0.001 par value, of Hamilton Lane Incorporated, a Delaware corporation (the “Issuer”), to amend and supplement the Schedule 13D filed on March 17, 2017 (as amended and supplemented to date, the “Schedule 13D”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Schedule 13D filed on March 17, 2017.

    Item 1 of the Schedule 13D is hereby amended to reflect that the principal executive offices of the Issuer are located at 110 Washington Street, Suite 1300, Conshohocken, PA 19428.

    Item 2. Identity and Background

    Items 2(a), 2(b), 2(c) and 2(f) of the Schedule 13D are hereby amended and restated in their entirety:

    (a)As of the date of this Amendment No. 10:
    (i)    HLAI beneficially owns 18,023,993 shares of Class A common stock as holder of 9,328,657 Class B units and because it has voting control over an additional 8,695,336 shares of Class A common stock. HLAI’s principal business is to hold Class B units of HLA and Class B common stock of the pre-IPO investor group, including certain members of senior management of the Issuer and outside investors.
    (ii)    HRHLA beneficially owns 18,023,993 shares of Class A common stock as the managing member of HLAI. HRHLA’s principal business is to hold the membership interests in HLAI representing its ownership in the Issuer.
    (iii)    Hartley R. Rogers beneficially owns 18,023,993 shares of Class A common stock, which includes 7,300,667 shares as the managing member of HRHLA and 10,503 shares held directly.
    (iv)    HLA Inc. beneficially owns 2,579,104 shares of Class A common stock as holder of 2,579,104 Class B units. HLA Inc.’s principal business is to hold Class B units on behalf of Mario L. Giannini, its sole stockholder and director.
    (v)    Mario L. Giannini beneficially owns 3,408,829 shares of Class A common stock, which includes 449,595 shares of Class A common stock beneficially held through Class B units held directly, the 2,579,104 shares of Class A common stock beneficially held by HLA Inc., 283,632 shares of Class A common stock beneficially held as a result of his ownership interest in HLAI, and 96,498 shares of Class A common stock held directly.
    (vi)    Kyera Giannini beneficially owns 288,648 shares of Class A common stock as a result of her ownership interest in HLA.
    (vii)    Nicole Giannini beneficially owns 288,648 shares of Class A common stock as a result of her ownership interest in HLA.
    (viii)    The Laura Sexton Trust beneficially owns 366,233 shares of Class A common stock as a result of its ownership interest in HLAI.
    (ix)    The Matthew Sexton Trust beneficially owns 366,233 shares of Class A common stock as a result of its ownership interest in HLAI.
    (x)    O. Griffith Sexton beneficially owns 749,880 shares of Class A common stock, which includes 732,466 shares as sole trustee of the two Sexton family trusts and 17,414 shares of Class A common stock held directly. Barbara Sexton, Mr. Sexton’s wife and former co-trustee of the two Sexton family trusts, passed away in February 2023.
    (xi)    Oakville Trust directly owns 535,015 shares of Class A common stock and beneficially owns an additional 7 shares of Class A common stock as a result of the Oakville Trust’s ownership interest in HLAI. Rysaffe, the trustee of Oakville Trust, beneficially owns all of such shares.
    (xii)    Edward B. Whittemore beneficially owns 130,000 shares of Class A common stock as a result of his ownership interest in HLAI.
    (xiii) Laurence F. Whittemore beneficially owns 156,880 shares of Class A common stock as a result of his ownership interest in HLAI.
    28

    SCHEDULE 13D/A
    CUSIP No. 407497 106
    (xiv)    Michael Schmertzler beneficially owns 725,005 shares of Class A common stock as a result of his ownership interest in HLAI.
    (xv)    The Management Investors collectively beneficially own 1,540,700 shares of Class A common stock directly, an additional 160,160 shares of restricted Class A common stock subject to vesting, and 2,729,051 shares of Class A common stock as holders of 2,330,061 Class B units and 398,990 Class C units held by HLMI. Pursuant to and under the terms and conditions of the exchange agreement, as amended (the “Exchange Agreement”), each Management Investor may exchange such Class B units and Class C units for shares of Class A common stock on a one-for-one basis.
    Each Reporting Person, other than Mr. Rogers, HLAI and HRHLA, disclaims beneficial ownership of securities owned by the other Reporting Persons, except to the extent of such Reporting Person’s pecuniary interest therein. Ms. Devlin also disclaims beneficial ownership of 565 shares of Class A common stock owned by her son, who lives at her home.
    (b) The business address of each of the Reporting Persons is c/o Hamilton Lane Incorporated, 110 Washington Street, Suite 1300, Conshohocken, PA 19428.
    (c)Certain of the Reporting Persons hold positions at the Issuer and its subsidiaries as their principal occupation.
    NamePrincipal Occupation (at Issuer)
    Hartley R. RogersChairman, Director
    Mario L. GianniniChief Executive Officer, Director
    Erik R. HirschVice Chairman, Director
    Juan Delgado-MoreiraVice Chairman
    Michael DonohueController
    Paul YettDirector of ESG & Sustainability
    Tara DevlinManaging Director Relationship Manager
    Andrea AnigatiCo-Head of Fund Investments and Chief Operating Officer of Client Solutions
    Stephen R. BrennanHead of Private Wealth Solutions
    Thomas KerrHead of Secondaries
    David HelgersonManaging Director Direct Equity Investments

    (f) Each natural person identified in this Item 2 is a citizen of the United States except for Mr. Delgado-Moreira, who is a citizen of Spain. Each entity identified in this Item 2 is organized under the laws of Delaware, other than Hamilton Lane Advisors, Inc., which is a Pennsylvania corporation, Oakville Trust and Rysaffe, which are governed by the laws of Guernsey, and the Sexton Trusts, which are New York trusts.

    Item 3. Source and Amount of Funds or Other Consideration
     
    Item 3 of the Schedule 13D is hereby amended and supplemented as follows:

    The Issuer conducted a registered offering of Class A common stock, which closed on March 9, 2023 (the “March 2023 Offering”).  In connection with the March 2023 Offering, Oakville Trust (the “Selling Stockholder”) sold 100,000 shares of Class A common stock, while the Issuer sold 571,737 shares of Class A common stock for $76.41 per share to BofA Securities, Inc. The Issuer did not receive any proceeds from the sale of Class A common stock by the Selling Stockholder. The proceeds from the Issuer’s sale of shares of Class A common stock were used to settle in cash exchanges of Class B units (along with payment of the par value of a corresponding number of redeemed shares of Class B common stock) and Class C units of HLA by certain of the Reporting Persons. The redeemed shares of Class B common stock were cancelled.

    Item 4. Purpose of Transaction
     
    Item 4 of the Schedule 13D is hereby amended and supplemented as follows:

    Item 3 to this Amendment No. 10 is hereby incorporated by reference.

    29

    SCHEDULE 13D/A
    CUSIP No. 407497 106
    Pursuant to lock-up agreements, the Issuer, HLA, all of the Issuer’s directors and executive officers and certain of the Reporting Persons (collectively owning approximately 34% of the Issuer’s common stock as of March 6, 2023) agreed that, without the prior written consent of the underwriter for the March 2023 Offering, they will not, subject to specified exceptions, directly or indirectly, (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of the Issuer’s common stock or any securities convertible into or exercisable or exchangeable for such common stock (including without limitation, common stock or such other securities which may be deemed to be beneficially owned in accordance with the rules and regulations of the SEC and securities which may be issued upon exercise of a stock option or warrant), or publicly disclose the intention to make any offer, sale, pledge or disposition, (2) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Issuer's common stock or such other securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of common stock or such other securities, in cash or otherwise or (3) make any demand for or exercise any right with respect to the registration of any shares of the Issuer’s common stock or any security convertible into or exercisable or exchangeable for such common stock for a period of 75 days after the date of the prospectus supplement related to the offering. 

    Item 5. Interest in Securities of the Issuer 

    Items 5(a) and 5(b) of Schedule 13D are amended to reflect the following:

    The following table sets forth the aggregate number and percentage of the Class A common stock beneficially owned by each Reporting Person. The aggregate number of the Class A common stock beneficially owned by each Reporting Person is calculated in accordance with Rule 13d-3.
    Reporting PersonNumber of 
    Shares 
    Beneficially 
    Owned
    Percentage of Class 
    A Common Stock 
    Outstanding
    (1)
    HLAI18,023,99333.2 %
    HRHLA18,023,99333.2 %
    Hartley R. Rogers18,023,99333.2 %
    HLA Inc.2,579,1046.3 %
    Mario L. Giannini3,408,8298.1 %
    Kyera Giannini288,648*
    Nicole Giannini288,648*
    O. Griffith Sexton749,8801.9 %
    Laura Sexton Trust366,233*
    Matthew Sexton Trust366,233*
    Oakville Trust535,0221.4 %
    Rysaffe535,0221.4 %
    Edward B. Whittemore130,000*
    Laurence F. Whittemore156,880*
    Michael Schmertzler725,0051.8 %
    Erik R. Hirsch1,192,552 3.0 %
    Juan Delgado-Moreira1,280,902 3.3 %
    Paul Yett231,129 *
    Kevin J. Lucey216,426 *
    Tara Devlin221,850 *
    Stephen R. Brennan230,184 *
    Andrea Anigati449,930 1.2 %
    Michael Kelly100,000 *
    Thomas Kerr196,138*
    David Helgerson199,477*
    Michael Donohue62,094*
    30

    SCHEDULE 13D/A
    CUSIP No. 407497 106
    Total for Group17,202,098 33.3 %
    * Less than 1%
    (1)    Based on the number of shares of Class A common stock (38,593,105) issued and outstanding as of March 24, 2023, the date of this report, and assuming all outstanding Class B units and Class C units beneficially owned by the Reporting Person were exchanged for newly-issued shares of Class A common stock on a one-for-one basis.

    (c) Item 5(c) of Schedule 13D is hereby amended and supplemented as follows:

    The information set forth in Items 3 and 4 of this Amendment No. 10 is hereby incorporated herein by reference.

    The following table sets forth the transactions by the Reporting Persons involving the beneficial ownership of Class A Common stock that were effected during the last 60 days.
    Reporting Person
    Number of Class B Units Exchanged(1)
    Number of Class C Units Exchanged(2)
    Shares of Class A Common Stock Sold
    Shares of Class A Common Stock Granted(3)
    Shares of Class A Common Stock Withheld(4)
    Hartley R. Rogers––––1,468
    Mario L. Giannini500,000––––
    Oakville Trust––
    100,000(5)
    ––
    Jeffrey S. Meeker
    39,237(6)
    ––––
    Erik R. Hirsch–––13,8983,134
    Michael Donohue–––1,020451
    Juan Delgado-Moreira–––9,285–
    Paul Yett–––726346
    Tara Devlin–––2,6641,189
    Stephen R. Brennan–––6,2541,229
    Andrea Anigati–––5,5591,107
    Thomas Kerr–––6,9491,054
    David Helgerson–––1,699434

    (1)    Pursuant to the Exchange Agreement, the Class B Units of HLA are exchangeable, on a one-for-one basis, for shares of Class A common stock or, at the Issuer’s election, for cash. The column below represents Class B Units exchanged on March 9, 2023 in connection with the March 2023 Offering. At the Issuer’s election, the exchange was settled in cash at a price of $76.41.
    (2)    Pursuant to the Exchange Agreement, the Class C Units of HLA are exchangeable, on a one-for-one basis, for shares of Class A common stock or, at the Issuer’s election, for cash. The column below represents Class C Units exchanged on March 9, 2023 in connection with the March 2023 Offering. At the Issuer’s election, the exchange was settled in cash at a price of $76.41.
    (3)    Represents shares granted to the Reporting Person on March 14, 2023 pursuant to an award of restricted stock under the Issuer’s Amended and Restated 2017 Equity Incentive Plan. The awards are subject to a time-based vesting condition.
    (4)    Represents shares delivered to the Issuer on March 14, 2023 to satisfy withholding taxes due upon the vesting of previously granted restricted stock awards. The forfeiture price was $64.76.
    (5)    Represents Class A common shares sold on March 9, 2023 at a price of $76.41 in the March 2023 Offering. Rysaffe Trust Company (CI) Limited serves as trustee of the trust.
    (6)    Represents securities held on behalf of the individual by HLMI. HLMI distributed the HLA units to the individual in order to facilitate the exchange.

    (e) Item 5(e) of Schedule 13D is hereby amended and supplemented as follows:

    The Stockholders Agreement terminated pursuant to its terms with respect to Jeffrey S. Meeker on March 9, 2023 due to the fact that Mr. Meeker ceased to beneficially own Class B units of HLA as of that date. As a result, Mr.
    31

    SCHEDULE 13D/A
    CUSIP No. 407497 106
    Meeker is no longer a Reporting Person hereunder. Other than with respect to Mr. Meeker, the Stockholders Agreement remains in full force and effect.
    32

    SCHEDULE 13D/A
    CUSIP No. 407497 106
    Item 7. Material to be Filed as Exhibits
    ExhibitDescription
    1.    
    Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
    2.Form of Lock-Up Agreement.

     

    33

    SCHEDULE 13D/A
    CUSIP No. 407497 106
    SIGNATURES
     
    After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned, severally and not jointly, certifies that the information set forth in this statement is true, complete and correct.
     
    Dated: March 24, 2023
    1.HLA Investments, LLC
    By:/s/ Lauren Platko
    Name:Lauren Platko
    Title:Attorney-in-Fact
    2.HRHLA, LLC
    By:/s/ Lauren Platko
    Name:Lauren Platko
    Title:Attorney-in-Fact
    3.Hamilton Lane Advisors, Inc.
    By:/s/ Lauren Platko
    Name:Lauren Platko
    Title:Attorney-in-Fact
    4./s/ Lauren Platko, Attorney-in-Fact
    Hartley R. Rogers
    5./s/ Lauren Platko, Attorney-in-Fact
    Mario L. Giannini
    6./s/ Lauren Platko, Attorney-in-Fact
    Kyera Giannini
    7./s/ Lauren Platko, Attorney-in-Fact
    Nicole Giannini
    8./s/ Lauren Platko, Attorney-in-Fact
    O. Griffith Sexton
    9.The 2008 Sexton Des. Trust FBO Laura Sexton
    By:/s/ Lauren Platko
    Name:Lauren Platko
    Title:Attorney-in-Fact


    SCHEDULE 13D/A
    CUSIP No. 407497 106
    10.The 2008 Sexton Des. Trust FBO Matthew Sexton
    By:/s/ Lauren Platko
    Name:Lauren Platko
    Title:Attorney-in-Fact
    11.Oakville Number 2 Trust
    By:/s/ Lauren Platko
    Name:Lauren Platko
    Title:Attorney-in-Fact
    12.Rysaffe Trust Company (C.I.) Limited
    By:/s/ Lauren Platko
    Name:Lauren Platko
    Title:Attorney-in-Fact
    13./s/ Lauren Platko, Attorney-in-Fact
    Edward B. Whittemore
    14./s/ Lauren Platko, Attorney-in-Fact
    Laurence F. Whittemore
    15./s/ Lauren Platko, Attorney-in-Fact
    Michael Schmertzler
    16./s/ Lauren Platko, Attorney-in-Fact
    Erik R. Hirsch
    17./s/ Lauren Platko, Attorney-in-Fact
    Kevin J. Lucey
    18./s/ Lauren Platko, Attorney-in-Fact
    Juan Delgado-Moreira


    SCHEDULE 13D/A
    CUSIP No. 407497 106
    19./s/ Lauren Platko, Attorney-in-Fact
    Paul Yett
    20./s/ Lauren Platko, Attorney-in-Fact
    Tara Devlin
    21./s/ Lauren Platko, Attorney-in-Fact
    Andrea Anigati
    22./s/ Lauren Platko, Attorney-in-Fact
    Michael Kelly
    23./s/ Lauren Platko, Attorney-in-Fact
    Stephen R. Brennan
    24./s/ Lauren Platko, Attorney-in-Fact
    Thomas Kerr
    25./s/ Lauren Platko, Attorney-in-Fact
    David Helgerson
    26./s/ Lauren Platko, Attorney-in-Fact
    Michael Donohue






    Get the next $HLNE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    9/12/2024$156.00Equal Weight
    Wells Fargo
    4/11/2024$115.00Overweight → Neutral
    JP Morgan
    1/11/2024Outperform → Perform
    Oppenheimer
    5/26/2023$87.00Perform → Outperform
    Oppenheimer
    3/15/2023$85.00Neutral → Overweight
    JP Morgan
    8/9/2022$72.00 → $75.00Buy → Neutral
    UBS
    More analyst ratings

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      11/13/24 4:31:06 PM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hamilton Lane upgraded by Oppenheimer with a new price target

      Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $186.00

      1/21/25 7:49:57 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane downgraded by Goldman with a new price target

      Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00

      1/6/25 8:11:18 AM ET
      $HLNE
      Investment Managers
      Finance
    • Wells Fargo initiated coverage on Hamilton Lane with a new price target

      Wells Fargo initiated coverage of Hamilton Lane with a rating of Equal Weight and set a new price target of $156.00

      9/12/24 7:41:15 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider French River 5 Ltd claimed ownership of 480,015 shares and claimed ownership of 7 units of Class B Common Stock (SEC Form 3)

      3 - Hamilton Lane INC (0001433642) (Issuer)

      4/25/25 5:05:37 PM ET
      $HLNE
      Investment Managers
      Finance
    • Co-Chief Executive Officer Delgado-Moreira Juan was granted 34,031 shares, increasing direct ownership by 3% to 1,298,847 units (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      3/18/25 5:00:47 PM ET
      $HLNE
      Investment Managers
      Finance
    • Co-Chief Executive Officer Hirsch Erik R. was granted 36,001 shares and covered exercise/tax liability with 3,386 shares, increasing direct ownership by 37% to 120,275 units (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      3/18/25 4:58:27 PM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/13/24 9:56:40 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/12/24 3:55:46 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/4/24 11:53:29 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    See more

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $HLNE
    Financials

    Live finance-specific insights

    See more
    • Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

      Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

      4/23/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

      Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo

      2/10/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation

      Experienced commercial leader joins Cosette to drive the next phase of growth and transformation Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. In this role, Brad will spearhead Cosette's generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250203104224/en/Brad Leonard, Vice President, Generics Commercial Operations (Photo: Business Wire) "Cosette is

      2/3/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Results on May 29, 2025

      CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold

      5/8/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Launches U.S. Venture Capital and Growth Evergreen Fund, Further Expanding its $10B+ AUM Evergreen Platform

      Fund offers access to private venture and growth investments including disruptive technologies and innovative businesses CONSHOHOCKEN, Pa., May 6, 2025 /PRNewswire/ -- Leading private markets investment firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Venture Capital and Growth Fund ("HLVCG" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Act of 1940 ("40 Act"), available to accredited U.S. investor clients, including high-net-worth investors and their advisors2, as well as institutional investors. HLVCG offers investors in the U.S. access to the firm's global venture capital investment platform with what th

      5/6/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

      Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

      4/23/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Results on May 29, 2025

      CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold

      5/8/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • PAX Health Acquires Richardson Psychiatric Associates, Expanding Mental Health Services for Adults, Adolescents, and Families

      RED BANK, N.J., April 17, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Richardson Psychiatric Associates, a comprehensive outpatient psychiatric practice serving adults, adolescents, children, and families. This strategic acquisition enhances PAX Health's portfolio of mental health services and expands its geographic footprint in Western Pennsylvania, strengthening the company's ability to deliver high-quality psychiatric care across diverse

      4/17/25 8:27:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2025 RESULTS, WITH MANAGEMENT & ADVISORY FEES GROWING BY 11% AND ASSETS UNDER MANAGEMENT GROWING BY 12% YEAR-OVER-YEAR

      CONSHOHOCKEN, Pa., Feb. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2024. THIRD QUARTER FISCAL 2025 HIGHLIGHTS Assets under management – Total assets under management of $134.7 billion grew $14.8 billion year-over-year. Fee-earning assets under management increased $7.9 billion to $71.0 billion over the same period.Revenue – Management and advisory fees of $126.3 million for the quarter represent growth of 11% versus the prior year period.Carried Interest – Unrealized carried interest balance of approximately $1.3 billion, up 15% versus the prior year

      2/4/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

      SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)

      4/2/25 4:33:42 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

      SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)

      2/14/25 4:27:12 PM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Hamilton Lane INC (0001433642) (Filer)

      2/12/25 4:21:19 PM ET
      $HLNE
      Investment Managers
      Finance